IDWeek 2023 Post Show Hero Image

Visit Karius at Booth #506 during the 2024 ASPHO Conference!

April 3-6, 2024
The 2024 ASPHO Conference
Seattle Convention Center I Seattle, WA

Join the pediatric hematology/oncology subspecialist community in Seattle, Washington and learn the latest basic, translational, and clinical research and recommendations at a diverse mix of programs delivered by experts in the subspecialty. The ASPHO Conference delivers vital education and networking opportunities to subspecialist investigators and practitioners from every sector of the field including hospitalists, physician assistants, advanced nurse practitioners, other advanced practice providers, and allied healthcare professionals.

 

The results of the PICKUP Study have been published in Clinical Infectious Diseases.

What is the Karius Test?

The Karius Test is a blood test, based on metagenomic next-generation sequencing (mNGS) of plasma microbial cell-free DNA (mcfDNA). From a single blood sample, the Karius Test can rapidly and non-invasively detect over one thousand pathogens associated with deep-seated and bloodstream infections.

AMR Final Icon NEW ANTIMICROBIAL RESISTANCE DETECTION

In addition to detecting over 1,000 pathogens from blood, the Karius Test now offers a culture-independent method of detection for common AMR markers for 4 classes of antimicrobials across 18 bacterial pathogens:

  • Methicillin-resistant Staphylococci (SCCmec, mecA, mecC)
  • Vancomycin-resistant Enterococci (vanA, vanB)
  • Carbapenem-resistant Gram-negative bacteria (KPC)
  • Extended spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria (CTX-M)

1 blood sample  |  1-day processing*  |  1000+ pathogens

*The Karius Test provides pathogen detection results typically one day after sample receipt, with AMR marker determination available within one day after pathogen results.

The Karius Test® is a laboratory-developed test. The Karius Laboratory is certified under CLIA and accredited by CAP.

Stay up-to-date with Karius

Sign up today to receive notification of future real-world cases of the Karius Test being used by physicians and upcoming events.